Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of intravenous ketanserin on sublingual microcirculation in severe sepsis ICU patients
2010-023767-18Phase 3Active
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ketanserin in sepsis, sponsored by Medisch Centrum Leeuwarden. Primary endpoint: Achievement of MFI > 2.9. Started Jan 2011; status: active.
02
Drugs
ketanserin
03
Conditions
sepsis
Beyond the preview
Go deeper on 2010-023767-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023767-18.